Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanna Liuzzo

Showing results (11-20 of 271) with videos related to

Pageof 28
Sort By:
European Heart Journal|September 10, 2022
Long-term use of proton pump inhibitors and risk of diabetes mellitus: the totality of the evidence does not support a change in practiceGiovanna Liuzzo, Carlo Patrono
European Heart Journal|September 19, 2025
Weekly Journal Scan: Reframing inflammaging across the population spectrumDaniela Pedicino, Giovanna Liuzzo
European Heart Journal|September 19, 2025
Weekly Journal Scan: REDEFINing the next generation of obesity pharmacotherapyGiovanna Liuzzo, Carlo Patrono
European Heart Journal|May 13, 2022
A novel inhibitor of Factor XIa as potential haemostasis-sparing anticoagulant for patients with atrial fibrillationGiovanna Liuzzo, Carlo Patrono
European Heart Journal|September 20, 2024
Weekly Journal Scan: tirzepatide SURMOUNTs obesity-related obstructive sleep apnoeaGiovanna Liuzzo, Carlo Patrono
European Heart Journal|October 18, 2024
Weekly Journal Scan: Do older patients with non-ST-segment elevation myocardial infarction receive any benefit from a routine invasive strategy?Giovanna Liuzzo, Carlo Patrono
European Heart Journal|April 18, 2025
Weekly Journal Scan: Platelet thromboxane suppression as the mechanism of the anti-metastatic effect of aspirinGiovanna Liuzzo, Carlo Patrono
European Heart Journal|April 18, 2025
Weekly Journal Scan: long-term effects of tirzepatide for diabetes prevention in persons with obesity and prediabetesDaniela Pedicino, Giovanna Liuzzo
European Heart Journal|April 7, 2021
Interleukin-1 blockade: a paradigm shift in the treatment of patients with recurrent pericarditis?Giovanna Liuzzo, Carlo Patrono
European Heart Journal|October 7, 2020
Low-dose colchicine: a new tool in the treatment of chronic coronary disease? Comment on the low-dose colchicine (LoDoCo)2 trialGiovanna Liuzzo, Carlo Patrono
Pageof 28

Showing results (11-20 of 271) with videos related to

Sort By:
Pageof 28
European Heart Journal|September 10, 2022
Long-term use of proton pump inhibitors and risk of diabetes mellitus: the totality of the evidence does not support a change in practiceGiovanna Liuzzo, Carlo Patrono
European Heart Journal|September 19, 2025
Weekly Journal Scan: Reframing inflammaging across the population spectrumDaniela Pedicino, Giovanna Liuzzo
European Heart Journal|September 19, 2025
Weekly Journal Scan: REDEFINing the next generation of obesity pharmacotherapyGiovanna Liuzzo, Carlo Patrono
European Heart Journal|May 13, 2022
A novel inhibitor of Factor XIa as potential haemostasis-sparing anticoagulant for patients with atrial fibrillationGiovanna Liuzzo, Carlo Patrono
European Heart Journal|September 20, 2024
Weekly Journal Scan: tirzepatide SURMOUNTs obesity-related obstructive sleep apnoeaGiovanna Liuzzo, Carlo Patrono
European Heart Journal|October 18, 2024
Weekly Journal Scan: Do older patients with non-ST-segment elevation myocardial infarction receive any benefit from a routine invasive strategy?Giovanna Liuzzo, Carlo Patrono
European Heart Journal|April 18, 2025
Weekly Journal Scan: Platelet thromboxane suppression as the mechanism of the anti-metastatic effect of aspirinGiovanna Liuzzo, Carlo Patrono
European Heart Journal|April 18, 2025
Weekly Journal Scan: long-term effects of tirzepatide for diabetes prevention in persons with obesity and prediabetesDaniela Pedicino, Giovanna Liuzzo
European Heart Journal|April 7, 2021
Interleukin-1 blockade: a paradigm shift in the treatment of patients with recurrent pericarditis?Giovanna Liuzzo, Carlo Patrono
European Heart Journal|October 7, 2020
Low-dose colchicine: a new tool in the treatment of chronic coronary disease? Comment on the low-dose colchicine (LoDoCo)2 trialGiovanna Liuzzo, Carlo Patrono
Pageof 28